Standardised Drug Provocation Testing in Perioperative Hypersensitivity
NCT06065137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-09-08
Summary
The goal of this clinical trial is to evaluate the safety and outcome of systematic drug provocation testing with anaesthetics at therapeutic doses in adult patients undergoing diagnostic work-up for perioperative hypersensitivity.
Conditions
- Allergic Reaction
- Hypersensitivity
- Perioperative Complication
- Anaphylaxis
- Anaphylactic Reaction
- Immediate Hypersensitivity
- Hypersensitivity, Drug
Interventions
- DIAGNOSTIC_TEST
-
Full dose DPT with propofol
Incremental administration of propofol up to a cummulative full therapeutic dose (2mg/kg) in POH patients investigated for propofol. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.02mg/kg-0.2 mg/kg -0.6 mg/kg -1.2mg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with ketamine
Incremental administration of ketamine up to a cummulative full therapeutic dose (1mg/kg) in POH patients investigated for ketamine. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.01 mg/kg -0.1 mg/kg -0.3 mg/kg -0.6mg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with etomidate
Incremental administration of etomidate up to a cummulative full therapeutic dose (0.2mg/kg) in POH patients investigated for etomidate. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.002 mg/kg -0.02 mg/kg -0.06 mg/kg -1.2mg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with midazolam
Incremental administration of midazolam up to a cummulative full therapeutic dose (0.05mg/kg) in POH patients investigated for midazolam. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.0005 mg/kg -0.005 mg/kg -0.015 mg/kg -0.03mg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with fentanyl
Incremental administration of fentanyl up to a cummulative full therapeutic dose (1mcg/kg) in POH patients investigated for fentanyl. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.01 mcg/kg -0.1 mcg/kg -0.3 mcg/kg -0.6mcg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with sufentanyl
Incremental administration of sufentanyl up to a cummulative full therapeutic dose (0.1mcg/kg) in POH patients investigated for sufentanyl. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.001 mcg/kg -0.01 mcg/kg -0.03 mcg/kg -0.06µg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with alfentanil
Incremental administration of alfentanil up to a cummulative full therapeutic dose (10mcg/kg) in POH patients investigated for alfentanil. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.1 mcg/kg -1 mcg/kg -3 mcg/kg -6µg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with remifentanil
Incremental administration of remifentanil up to a cummulative full therapeutic dose (0.5mcg/kg) in POH patients investigated for remifentanil. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose, 3/10th of the dose and ultimately 6/10th of the dose (0.005 mcg/kg -0.05 mcg/kg -0.15 mcg/kg -0.3µg/kg).
- DIAGNOSTIC_TEST
-
Full dose DPT with rocuronium
Incremental administration of rocuronium up to a cummulative full therapeutic dose (0.6mg/kg) in POH patients investigated for rocuronium. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose (0.006 mg/kg -0.06 mg/kg ). In a second session 3/10th of the dose and ultimately 7/10th of the dose (0.18 mg/kg -0.42mg/kg) are administerd under general anesthesia.
- DIAGNOSTIC_TEST
-
Full dose DPT with atracurium
Incremental administration of atracurium up to a cummulative full therapeutic dose (0.5mg/kg) in POH patients investigated for atracurium. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose (0.005 mg/kg -0.05 mg/kg ). In a second session 3/10th of the dose and ultimately 7/10th of the dose (0.15 mg/kg -0.35mg/kg) are administered under general anesthesia .
- DIAGNOSTIC_TEST
-
Full dose DPT with cisatracurium
Incremental administration of cisatracurium up to a cummulative full therapeutic dose (0.15mg/kg) in POH patients investigated for cisatracurium. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose (0.0015 mg/kg -0.015 mg/kg ). In a second session 3/10th of the dose and ultimately 7/10th of the dose (0.045 mg/kg -0.105mg/kg) are administered under general anesthesia .
- DIAGNOSTIC_TEST
-
Full dose DPT with succinylcholine
Incremental administration of succinylcholine up to a cummulative full therapeutic dose (1mg/kg) in POH patients investigated for succinylcholine. Doses will be administered every 15 minutes starting at 1/100th of the dose, followed by 1/10th of the dose (0.01 mg/kg -0.1 mg/kg). In a second session 3/10th of the dose and ultimately 7/10th of the dose (0.3 mg/kg -0.7mg/kg) are administered under general anesthesia.
Sponsors & Collaborators
-
University Hospital, Antwerp
lead OTHER
Principal Investigators
-
Vera Saldien, MD,PhD · University Hospital Antwerp, Head of department of anesthesiology
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-23
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Intrathecal Fentanyl and Dexmedetomidine Added to Bupivacaine for Subarachnoid Anaesthesia for Percutaneous Nephrolithotomy
NCT06957301 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Topical Airway Block on Hemodynamic Stability Post Induction of Anaesthesia in Cardiac Surgeries
NCT06395727 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison Between Dexmedetomidine and Propofol-fentanyl Infusions for Sedation for Colonoscopy Procedures
NCT06148103 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic and Cardiac Effects of Dexmedetomidine Versus Fentanyl by Intravenous Infusion as Adjuncts to General Anesthesia in Patients Undergoing Major Abdominal Cancer Surgeries.
NCT07214714 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Comparative Analysis of Intraoperative Effect Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Spinal Anaesthesia in Lower Limb Orthopedic Surgeries to Evaluate the Hemodynamic Stability and Onset and Duration of Motor Block of Using Intrathecal Dexmedetomidine and Fentanyl
NCT07078201 ·Status: RECRUITING ·Phase: PHASE4
-
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
NCT06386783 ·Status: RECRUITING ·Phase: PHASE3
-
Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block
NCT06216197 ·Status: COMPLETED ·Phase: NA
-
To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
NCT07097441 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine
NCT05993975 ·Status: COMPLETED ·Phase: PHASE4
-
Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Assisted Thoracoscopic Surgery.
NCT03809442 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Intravenous Anesthesia
NCT02777619 ·Status: COMPLETED ·Phase: PHASE4
-
Lidocaine Versus Fentanyl for Hemodynamic Stability
NCT06557473 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block
NCT03778671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dexmedetomidine Versus Fentanyl As Adjuvants to Erector Spinae Plane Block for Postoperative Analgesia Following Simple Nephrectomy: a Randomized Clinical Trial
NCT06799442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
D-FAB-POUR Trial: Dexmedetomidine vs Fentanyl as Adjuvants to Bupivacaine on Postoperative Urinary Retention
NCT07117565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Effect of Desflurane on Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting
NCT02213718 ·Status: UNKNOWN ·Phase: PHASE4
-
Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy
NCT05225610 ·Status: COMPLETED ·Phase: NA
-
The Clinical Study on Pseudo-allergic Reaction to Anesthetic Drugs During General Anesthesia
NCT03157180 ·Status: UNKNOWN
-
Role of Dexmedetomidine as Synergistic Agent
NCT06662175 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Determination of the Effects of Change in Anxiety Level on Pain Perception in Patients Who Present to Emergency Department
NCT03420911 ·Status: COMPLETED ·Phase: NA
-
Sedation With Dexmedetomidine Versus Remifentanil in Urogynecological Surgery Under Spinal Anaesthesia
NCT03883347 ·Status: UNKNOWN ·Phase: PHASE3
-
A Comparative Study of the Effect of Epidural Dexmedetomidine Versus Fentanyl Added to Ropivacaine in Pediatric Orthopedic Surgery
NCT02375191 ·Status: COMPLETED ·Phase: NA
-
Is it Possible to Replace Fentanyl in Anesthesia for Minor Procedures?
NCT03806374 ·Status: COMPLETED ·Phase: NA
-
Intrathecal Additives to Prevent Post Spinal Shivering in Transurethral Prostatectomy
NCT04178512 ·Status: UNKNOWN ·Phase: NA
-
Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block
NCT06899841 ·Status: RECRUITING ·Phase: PHASE2/PHASE3